| Product NDC: | 53877-005 |
| Proprietary Name: | TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative |
| Non Proprietary Name: | Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative |
| Active Ingredient(s): | & nbsp; Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53877-005 |
| Labeler Name: | Terumo Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA880217 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091215 |
| Package NDC: | 53877-005-01 |
| Package Description: | 30 BAG in 1 CASE (53877-005-01) > 1 KIT in 1 BAG * 35 mL in 1 BAG * 56 mL in 1 BAG |
| NDC Code | 53877-005-01 |
| Proprietary Name | TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative |
| Package Description | 30 BAG in 1 CASE (53877-005-01) > 1 KIT in 1 BAG * 35 mL in 1 BAG * 56 mL in 1 BAG |
| Product NDC | 53877-005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative |
| Dosage Form Name | KIT |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091215 |
| Marketing Category Name | NDA |
| Labeler Name | Terumo Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |